Sniffing out the teased Obesity stocks from Dave Lashmet's Stansberry Venture Technology
14 Comments Read MoreWe use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info
Comments
Haven't written about that particular tease, but I suspect he was probably looking at Viking Therapeutics (VKTX)...
I too have accumulated some VKTX. I think it has a lot of promise and is a likely buy-out candidate for others in the s...
I owned this one in the past and did make a small amount of money on it. I thought for sure he would be touting VKTX (w...
I'm thinking it's probably VKTX, which I bought a small number of shares for under $15 about 6 months ago. Yesterday it...
$VKTX is best in class so far with glp-1/ gip dual at same stage P1. Starting oral version wit P1 results due 2h 2023. ...
$VKTX VK2735 is the other gip/glp-1 dual is starting an oral phase 1a after a successful phase 1a subc. At a $2.1b va...
$VKTX starter position Friday p.m. $DYODD #NIAIA + $VKTX Lynn or Travis please :-)#MondayMotivation + ...
$FATE offering at $13.50 http://ir.fatetherapeutics.com/news-releases/news-release-details/fate-therapeutics-announces...